Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 4/2017

01-07-2017 | Highlights

News and views

Author: Sander M. Houten

Published in: Journal of Inherited Metabolic Disease | Issue 4/2017

Login to get access

Excerpt

Lysine acetylation is an important posttranslational modification of proteins and plays a role in many biological pathways, such as epigenetic regulation of gene expression. In addition, lysine in protein can be acylated with a variety of other molecules, including propionyl, butyryl, and malonyl groups. While sirtuins are now known to be nicotinamide adenine dinucleotide (NAD)+-dependent protein deacylases that catalyze the removal of these modifications, the identification of specific acyltransferases that perform the acylation reaction has been challenging. Indeed, there is evidence that acyl-CoAs are reactive molecules that can chemically (nonenzymatically) modify proteins. In inborn errors of acyl-CoA metabolism, aberrant protein acylation is a frequent observation, but it is currently unknown whether it plays a role in pathophysiology (Pougovkina et al. 2014; Tan et al. 2014). Wagner et al. now show that short-chain dicarboxylate-CoAs, such as succinyl-, glutaryl- and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), are inherently unstable and form a highly reactive anhydride after ring closure (Wagner et al. 2017). As a consequence, the proteome of liver mitochondria isolated from HMG-CoA lyase knockout (KO) mice is heavily HMGylated and that of glutaryl-CoA dehydrogenase KO mice is heavily glutarylated. Wagner et al. further demonstrate that many protein sites are uniquely modified by either HMG-CoA or glutaryl-CoA, but some pathways, such as the tricarboxylic acid cycle, are commonly modified (Wagner et al. 2017). Given that these modifications affect the activity of many enzymes, protein acylation has been proposed as a biological regulatory mechanism that controls metabolism. Alternatively, many acylation events may be collateral damage of metabolic processes, requiring a repair mechanism that is in turn provided by the sirtuins. Regardless, this new work further establishes evidence that aberrant protein acylation may be a recurring theme in the pathophysiology of inborn errors of metabolism. …
Literature
go back to reference Pougovkina O, te Brinke H, Wanders RJ, Houten SM, de Boer VC (2014) Aberrant protein acylation is a common observation in inborn errors of acyl-CoA metabolism. J Inherit Metab Dis 37:709–714CrossRefPubMed Pougovkina O, te Brinke H, Wanders RJ, Houten SM, de Boer VC (2014) Aberrant protein acylation is a common observation in inborn errors of acyl-CoA metabolism. J Inherit Metab Dis 37:709–714CrossRefPubMed
go back to reference Wagner GR, Bhatt DP, O’Connell TM et al (2017) A class of reactive acyl-CoA species reveals the non-enzymatic origins of protein acylation. Cell Metab 25(823–837):e828 Wagner GR, Bhatt DP, O’Connell TM et al (2017) A class of reactive acyl-CoA species reveals the non-enzymatic origins of protein acylation. Cell Metab 25(823–837):e828
Metadata
Title
News and views
Author
Sander M. Houten
Publication date
01-07-2017
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 4/2017
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0062-2

Other articles of this Issue 4/2017

Journal of Inherited Metabolic Disease 4/2017 Go to the issue